RAIDEN RESOURCES LIMITED — Capital/Financing Update 2006

Oct 24, 2006

Update on Medical Monitors and NASDAQ OTC Listing

Sydney, Australia: 25 October 2006:

Under Listing Rule 15.4.2, and as previously announced to the ASX on 15 August, 2006, the Directors of Medical Monitors (ASX: MDM) now provide the material terms of the convertible note ("Promissory Note") offered as part of the reverse merger of its international distribution company. Primedical International Limited (PMI) with Global Immune Technologies, Inc. (GIMU) which will become Primedical International Holdings (Primedical) on the NASDAQ OTC Bulletin Board.

In the attached "Promissory Note". GIMU has made an offer of USD $4.0 million in shares in the newly merged Primedical for the transfer of the relevant IP for the US designed 'suPER' ECG and BPfone monitors. The listing of the newly merged Primedical on the NASDAQ OTC Bulletin Board will then be completed and all filings are with the US Securities Exchange Commission - including the transfer of the IP to the US entity. The transfer of the relevant IP is subject to shareholder approval at the forthcoming Medical Monitors' Annual General Meeting of Shareholders.

In the merger, GIMU will acquire PMI and its wholly-owned subsidiary, iCardia Healthcare Corporation (iCardia), the wholly owned North American cardiac monitoring service, for a combination of convertible debt and equity. Primedical will continue to distribute MDM's cutting edge Australian designed technology through iCardia into the US monitoring market.

Significantly, PMI - iCardia directors have informed MDM that baseline sales have increased by more than 68%, when compared to the previous year, with a quarterly growth of more than 30% already seen through 2006. The directors remain very confident of the continuing exponential growth in 2007.

The benefits of the overall transaction to MDM shareholders will be the significant shareholding in a US listed entity, that will increase as the business expands into the US and the EU markets.

Dr Allan Shell, Managing Director of MDM, said: "Our retained equity position in Primedical will provide Medical Monitors with an increased portfolio of assets, and the progressive sale of product and service in the USA will be reflected in an increasing share price of the US entity".

Detailed information is provided in the attached "Promissory Note" document noted as Annexure A

For further information, please contact:

Dr Allan Shell Managing Director $+61293448100$ ashell@medmon.com.au

About Medical Monitors:

Medical Monitors (ASX: MDM) is a health sector company generating revenue from investment in medical technology and resort lifestyle property for the over 50s. The company specialises in home-based medical monitoring technology which allow doctors to remotely monitor the cardiovascular health of their patients. The technologies have been granted US Food and Drug Administration (FDA) registration to enable marketing and sales. (www.medmon.com.au)

Medical Monitors Limited Suite 407 Westfield Eastgardens Eastgardens NSW 2036 Tel (02) 9344 8100 Fax (02) 9344 8200 Web site: www.medmon.com.au

About Primedical International:

The merged Company, to be named Primedical International Holdings, Inc., will have newly appointed Directors and will be engaged in the business of telemedicine and remote ambulatory monitoring. The Company will acquire iCardia Healthcare Corporation, located in Lake Forest, Illinois, which has revolutionized the ECG monitoring service marketplace with its unique 'single-use' approach to ECG monitoring, creating unprecedented convenience for physicians and new levels of security for patients.

Primedical's strategy is to rapidly grow its current business in North America through iCardia, and to expand into Europe using MDM's cutting edge Australian designed technology for the US arrhythmia monitoring market. Frost and Sullivan have estimated that the US market for all monitoring devices in 2004 was worth US$296million and that the associated services market was worth up to US$3.24 billion. (www.primedical.com)

About iCardia Healthcare Corporation:

iCardia's Single Use Patient Event Recorder (suPER) and proprietary application systems were developed by Medical Monitors and provide groundbreaking innovations in the diagnosis and treatment of cardiac arrhythmias. The lightweight, simple monitor boosts patient compliance, is absolutely hygienic and delivers high quality data. The service rapidly receives ECG transmissions and produces reports that can be viewed, annotated, and stored electronically, thereby enhancing analysis, interpretation, and mean time to diagnosis.(www.icardia.com)

Medical Monitors Limited Suite 407 Westfield Eastgardens Eastgardens NSW 2036 Tel (02) 9344 8100 Fax (02) 9344 8200 Web site: www.medmon.com.au

ANNEXURE A Promissory Note

THIS NOTE AND THE SECURITES ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR UNDER THE SECURITIES LAWS OF ANY STATE. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM.

CONVERTIBLE PROMISSORY NOTE

$4,000

0,000		Wyoming
$\frac{1}{2}$Dated this	$u_{\text{day of}}$ $A \mu \in \mathfrak{q}$	2006

FOR VALUE LECEIVED, the undersigned, Global Immune Technologies, Inc., a corporation organized under the laws of the State of Wyoming, USA (the "Corporation"), agrees and promises to nay to Medical Monitors Limited, a corporation organized under the laws of New South Walcs, Australia (the "Holder") at its office at Suite 407, Westfield Office Tower, Eastgardens, New South Wales, or at such other place or places as the Holder may designate in writing, the principal amount of FOUR MILLION and NO/100 United States Dollars ($4,000,000.00), in legal tender of the United States of America, in immediately available funds, as follews;

The unpaid principal amount from time to time outstanding shall not $(a)$ bear interest.

The entire principal amount of this Note, without any interest thereon, $(b)$ shall be payable at any time before July 21, 2007 (the "Maturity Date") upon the written agreement of the Corporation and the Holder.

In the exent the principal amount of this Note has not been paid prior to (c) the Maturity Date, as of the Maturity date this Note will automatically convert into a number of shares of the Corporation's common stock to be calculated pursuant to Section 5(b), below.

Place and Manner of Payment. All sums due under this Note are payable in 2. logal tender of the United States of America current on the dates such sums or payments are respectively due, in immediately available funds. All payments shall be made at the option of the Holder by wire transfer to a bank account designated in writing to the Corporation by the Holder and, if no such designation has been made by the Holder, by chack mailed by certified or registered mail to the address of the Holder.

Events of Default, Consequences. In the event of the occurrence of an Event Б. of Default (as defined) the Holder may declare the entire unpaid principal balance of this Note, together with interest accrued, immediately due and payable at the place of payment. The term "Event of Default" shall mean: the Corporation shall make an assignment for the benefit of creditors or admit in writing its inability to pay its debts generally as they become due or fail to generally pay its debts as they become due; an order, judgment or decree shall be entered for relief in respect of or adjudicating the Corporation bankrupt or insolvent; the Corporation or any of its subsidiaries shall petition or apply to any tribunal for the appointment of, or taking of possession by, a trustee, receiver, custodian, or liquidator or other similar official of the Corporation or any subsidiary or of any substantial part of any of their respective assets; the Corporation or any of its subsidiaries shall commence any proceeding relating to the Corporation or any subsidiary under any bankruptcy, reorganization, arrangement, insolvency, readjustment of debt, dissolution or liquidation law of any jurisdiction, or any such petition or application is filed or any such proceeding is commenced against the Corporation or any of its subsidiaries and such petition, application or proceeding is not dismissed within 60 days.

$\overline{4}$ Costs of Collection. The Corporation shall pay all costs and expenses of collection incurred by the Holder, including reasonable attorneys' fees.

5. Conversion.

$(a)$ The Holder may at any time prior to the Maturity Date convert the principal amount of this Note into a number of fully paid and nonassessable shares of the Common Stock, no par value per share, of the Corporation (the "Common Stock"), at a price equal to Eighty-Five Percent $(85%)$ of the average closing price (meaning the price of the last transaction booked during regular market hours, and exclusive of after-hours trading), of the Corporation's Common stock over the immediately preceding five business days, provided, however, that such conversion price shall not be less than Forty Cents (US $ 0.40) or greater than One Dollar (US $1.00) per share. Such conversion shall be effected by the surrender of this Note at the principal office of the Corporation (or such other office or agency of the Corporation in the continental United States as the Corporation may designate by notice in writing to the Holder) at any time during usual business hours, together with notice in writing that the Holder wishes to convert this Note, which notice shall also state the name(s) (with addresses) and denominations in which the certificate(s) for Common Stock shall be issued and shall include instructions for delivery thereof. Such conversion shall be deemed to have been effected as of the close of business on the date on which this Note shall have been surrendered and such notice shall have been received, and at such time (the "Voluntary Conversion Date") the rights of the Holder with respect to the principal amount of the Note converted shall cease and the person(s) in whose name(s) any certificate(s) for Common Stock are to be issued upon such conversion shall be deemed to have become the holder or holders of record of the shares of Common Stock represented by such certificate(s). As soon as practicable after the Voluntary Conversion Date, the Corporation shall deliver to, or as directed by, the Holder, certificates representing the number of shares of Common Stock issuable by reason of such conversion registered in such name or names and such denomination or denominations as the Holder shall have specified, together with cash as provided in Section 7 in respect of any fraction of a share of such stock otherwise issuable upon such conversion.

(b) In the event that the principal amount of this Note has not been repaid prior to the Maturity Date, as of the Maturity date this Note will automatically convert into a number of fully paid and nonassessable shares of the Common Stock, no par value per share, of the Corporation (the "Common" Stock"), at a price equal to Eighty-Five Percent (85%) of the average closing price (meaning the price of the last transaction booked during regular market hours, and exclusive of after-hours trading), of the Corporation's Common stock over the immediately preceding five business days, provided, however, that such conversion price shall not be less than Forty Cents (US $ 0.40) or greater than One Dollar (US $1.00) per share. Such conversion shall be deemed to have been effected as of the close of business on the Maturity Date, and at such time the rights of the Holder with respect to the principal amount of the Note converted shall cease, and the Holder shall designate to the Corporation the person(s) in whose name(s) any certificate(s) for Common Stock are to be issued in connection with such conversion. As soon as practicable after the Maturity Date, the Corporation shall deliver to, or as directed by, the Holder, certificates representing the number of shares of Common Stock issuable by reason of such conversion registered in such name or names and such denomination or denominations as the Holder shall have specified, together with cash as provided in Section 7 in respect of any fraction of a share of such stock otherwise issuable upon such conversion.

Reservation of Common Stock; Etc. 6.

The Corporation will at all times from and after this date reserve and $(a)$ keep available out of its authorized but unissued shares of Common Stock or its treasury shares, or otherwise, solely for the purpose of issuance upon the conversion of this Note, such number of shares of Common Stock as shall then be issuable upon the conversion of this Note. The Corporation covenants that all shares of Common Stock which shall be so issuable shall, when issued, be duly and validly issued, fully paid and nonassessable and free from all taxes, liens and charges.

The Corporation will not take any action which would result in any (b) adjustment of the number of shares of Common Stock acquirable upon conversion of this Note if the total number of shares issuable after such action upon conversion of this Note, together with the total number of shares of Common Stock then outstanding, would exceed the total number of shares of Common Stock then authorized under the Corporation's Certificate of Incorporation which are not reserved or required to be reserved for any purpose other than the purpose of issue upon conversion of this Note.

The issuance of certificates for shares of Common Stock upon $(c)$ conversion of this Note shall be made without charge to the Holder for any issuance tax or other cost incurred by the Corporation in connection with such conversion and the related issuance of shares of Common Stock.

1. The Corporation shall not be required to issue any Fractional Interests. fractional shares of Common Stock on the conversion of this Note. If any fraction of a share of Common Stock except for the provisions of this paragraph would be issuable upon

conversion of this Notel the Corporation shall purchase such fraction for an amount in cash equal to the current Market Price (as determined pursuant to Section 7(b) of this Note) of such fraction on the last Business Day prior to conversion.

Voting. Nothing contained in this Note shall be construed as conferring upon 8. the Holder the right to vote or to consent or to receive notice as a stockholder in respect of the meetings of stockholders for the election of directors of the Corporation or any other matter.

9.1 Notices.

(a). Any notice pursuant to this Note to be given or made by the Holder to or upon the Corporation shall be sufficiently given or made if sent by certified or registored mail, postage prepaid, addressed (until another address is sent by the Corporation to the Holder) as follows:

Suite 40%, Westfield Office Tower, Eastgardens. New South Wales

Any notice pursuant to this Note to be given or made by the Corporation to or $(b)$ upon the Holder shall be sufficiently given or made if sent by certified or registered mail. postage prepaid, addressed (until another address is sent by the Holder to the Corporation) to the address of the Holder set forth above.

1. Governing Law. This Note shall be governed by and construed in accordance with the internal laws of the State of Wyoming.

$11.$ Modification and Waiver. No modification or waiver of any provision of this Note, nor any departure by the Corporation therefrom, shall in any event be effective unless the same shall be in writing signed by the Holder and then such modification or waiver shall be effective only in the specific instance for the specific purpose given.

IN WITNESS WHEROF, the undersigned has executed this Convertible Promissory Note as of the date first written above.

Global Immune Technologies Inc.,

Name: Don Parks Its: Chief Executive Officer